Option chain shows key data for Trees's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Trees.

Trees (OTC:CANN) Stock, Option Chain

Trees

Trees Corp is a vertically integrated cannabis company and multi-state operator in the United States. It has two segments Retail and Cultivation. It is pursuing a roll-up plan of licensed assets in mature markets while maintaining loyal, local customer bases. TREES owns and operates a light-deprivation greenhouse and a campus of indoor cultivation facilities in Boulder, dispensaries in Englewood, Longmont, and Berthoud, Colorado, and three dispensaries in Portland, Oregon.

AI-Generated Image

Cannabis

News

Politics

Markets

ETFs

CANN

CRBP

CRLBF

CRON

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GRWG

GTBIF

HITI

IIPR

MJNA

MSOS

PLNHF

SNDL

TCNNF

TLRY

YOLO

HEXO

Trump confirmed his support for recreational cannabis in Florida. and sparked a reaction in the cannabis stock market on Monday.

Cannabis Stocks React To Trump&#39;s Marijuana Comments: See Which Ones Posted Solid Gains

Small Cap Analysis

Small Cap

Trading Ideas

Stocks in the cannabis sector showed varied reactions on Wednesday, after Trump&#39;s comments on the legalization of marijuana in Florida.

Trump&#39;s Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

Analyst Color

Government

Market Summary

Analyst Ratings

CNTMF

The market&#39;s response was immediate and pronounced. Cannabis stocks plummeted, with MOSOS ETF dropping over 10% in early trading.

Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024?

Trees Corp

CANNAISSEUR GROUP INC by CANNAISSEUR GROUP INC.

CANNIS INC by Cannis Inc.

CANN AMERICAN CORP by Cann American Corp.

Cann American Corp

Cann Group Ltd

CANNAMERICA BRANDS CORP by Cannamerica Brands Corporation

CannAmerica Brands Corp

CannLabs Inc

CANNTRUST HLDGS INC ORD by Canntrust Holdings Inc.

CannTrust Holdings Inc

Canna Corp

CANNA-GLOBAL ACQ CORP A by Canna-Global Acquisition Corp.

Canna Global Acquisition Corp

Canna Global Acquisition Corp Units (1 Ord Share Class A & 1 War)

Canna Global Acquisition Corp Warrants (30/11/2026)

CannaGrow Holdings Inc

Cannabis Bioscience International Holdings Inc

CANNABIS BIOSCI INTL HLDG by CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.

CANNABIS GLOBAL INC by Cannabis Global, Inc.

Cannabis Global Inc

CANNABIS STRATEG VNTRE by Cannabis Strategic Ventures

Cannabis Strategic Ventures

CANNABIS SUISSE CORP by Cannabis Suisse Corp.

Cannabis Suisse Corp

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

Cannabist Company Holdings Inc

CANNABIX TECHS INC ORD by Cannabix Technologies Inc.

Cannabix Technologies Inc

CANNABIZ MOBILE INC by Cannabiz Mobile, Inc.

Cannabiz Mobile Inc

Cannabotech Ltd

CANNABUSINESS GROUP INC by Cannabusiness Group, Inc.

Cannabusiness Group Inc

Cannae Holdings Inc

Cannagistics Inc

Cannalink Inc

Cannapharmarx Inc

Cannara Biotech Inc

CANNARA BIOTECH INC by Cannara Biotech Inc.

Cannonau Corp

CANNTAB THERAPEUTICS LTD by Canntab Therapeutics Ltd

Canntab Therapeutics Ltd

AAWH

ALEAFIA HEALTH INC ORD by Aleafia Health Inc.

ALEAF

AUSAF

AVTBF

AYRWF

BBRRF

BHHKF

BLOZF

BMMJ

CBDY

CBMJ

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CHOOF

CLSH

CLVR

CNBS

CNBX

CNGGF

CNPOF

CNVCF

CPHRF

CURE PHARMA HLDG CORP by CURE Pharmaceutical Holding Corp.

CURR

CVHIF

CVSI

CWBHF

CANNIBIS GROWTH OPTY CORP by Cannabis Growth Opportunity Corp.

CWWBF

CXXIF

ELLXF

EMOR

ETST

EVIO

FFLWF

FFNTF

FUTURE FARM TECHNOLOGIES by Future Farm Technologies Inc.

FFRMF

FLGC

FLOOF

FLWPF

FINCANNA CAPITAL CORP by Fincanna Capital Corp.

FNNZF

FUAPF

GABRIELLAS KITCHEN INC by Gabriella's Kitchen Inc.

GABLF

GBHPF

GENE

GHBWF

GLASF

GNLN

GRAMF

GRNH

GREEN SPIRIT INDUSTRIES by Green Spirit Industries Inc.

GSRX

HBOSF

HEMP

HERTF

HHPHF

HMLSF

INCR

INLB

ISODIOL INTERNATIONAL ORD by Isodiol International Inc.

ISOLF

ITHUF

IVITF

JWCAF

KALY

KAYS

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LFCOF

LFLY

LIFD

LMLLF

LNLHF

LOVFF

LRSNF

LVRLF

LXLLF

MAPS

MGCLF

MGWFF

MJNE

MJUS

MMNFF

MPXOF

MRMD

NDVAF

NOBDF

NWVCF

OILFF

PHOT

PKPH

Dropbox shares are trading higher after the company secured a $2 billion term loan facility led by Blackstone, authorized a $1.2 billion share repurchase program, and stated it expects to meet or exceed Q4 and FY 2024 guidance.

General

AP Reports Florida Voters Reject Cannabis Legalization; Amendment 3 Did Not Secure 60% Of Vote

Microsoft shares are trading higher after the company reported better-than-expected Q1 2025 GAAP EPS and sales.

Former President Donald Trump announced on Sunday night that, if re-elected, he would reschedule cannabis and support banking reforms for the marijuana industry. He also confirmed his support for Florida's Amendment 3, which would legalize recreational cannabis in the state. Trump's <a href="https://www.benzinga.com/markets/cannabis/24/09/40774795/trump-says-hell-reschedule-cannabis-if-elected-backs-marijuana-banking-reform-and-floridas-amend">comments</a> sparked a reaction in the cannabis stock market on Monday.
Get Benzinga's exclusive analysis and top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you're serious about the business, you can't afford to miss out.
<h3 class="wp-block-heading">Stocks Reaction</h3>
<ul>
<li>Trulieve Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>): The price at market close was $10.99 with a change of +$1.28 (+13.18%). Trading volume reached 707,392, with a market cap of $2.06 billion.</li>
<li>Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>): The price at market close was $10.66 with a change of +$1.02 (+10.58%). Trading volume hit 473,092, with a market cap of $2.52 billion.</li>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>): The price at market close was $3.10 with a change of +$0.26 (+9.15%). Trading volume reached 639,920, and the market cap stood at $2.09 billion.</li>
<li>Canopy Growth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>): The price at market close was $4.86 with a change of +$0.38 (+8.54%). Trading volume was 6,041,892, with a market cap of $412 million.</li>
<li>Sundial Growers (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>): The price at market close was $2.14 with a change of +$0.16 (+8.08%). Trading volume hit 1,946,306, and the market cap was $530 million.</li>
<li>Aurora Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>): The price at market close was $5.80 with a change of +$0.39 (+7.25%). Trading volume was 1,136,294, with a market cap of $317 million.</li>
<li>Cronos Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>): The price at market close was $2.21 with a change of +$0.07 (+3.27%). Trading volume reached 1,448,055, with a market cap of $847 million.</li>
<li>HEXO Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEXO#NASDAQ">HEXO</a>): The price at market close was $1.35 with a change of +$0.05 (+3.85%). Trading volume was 1,215,840, with a market cap of $401 million.</li>
<li>AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>): The price at market close was $7.16 with a change of +$0.75 (+11.70%). Trading volume hit 13,998,304.</li>
<li>Innovative Industrial Properties (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>): The price at market close was $122.69 with a change of +$2.02 (+1.67%). Trading volume was 90,181, with a market cap of $3.42 billion.</li>
<li>GrowGeneration (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>): The price at market close was $1.92 with a change of +$0.05 (+2.96%). Trading volume hit 454,306, and the market cap was $110 million.</li>
<li>Corbus Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>): The price at market close was $52.48 with a change of +$2.43 (+4.87%). Trading volume was 153,424, with a market cap of $630 million.</li>
<li>AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>): The price at market close was $3.35 with a change of +$0.21 (+6.69%). Trading volume reached 37,519.</li>
<li>Scotts Miracle-Gro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMG#NYSE">SMG</a>): The price at market close was $67.62 with a change of -$0.20 (-0.29%). Trading volume reached 323,540, with a market cap of $3.85 billion.</li>
<li>Village Farms International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VFF#NASDAQ">VFF</a>): The price at market close was $1.01 with a change of +$0.01 (+1.02%). Trading volume hit 459,136, and the market cap was $113 million.</li>
<li>Trees (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>): The price at market close was $0.042 with a change of -$0.012 (-22.22%). Trading volume was 118,407.</li>
<li>Medical Marijuana (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>): The price at market close was $0.001 with no change. Trading volume hit 9,393,761, with a market cap of $5.68 million.</li>
<li>OrganiGram Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>): The price at market close was $1.83 with a change of +$0.08 (+4.29%). Trading volume was 348,054, with a market cap of $186 million.</li>
<li>High Tide (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HITI#NASDAQ">HITI</a>): The price at market close was $2.12 with a change of +$0.16 (+8.16%). Trading volume hit 648,008, with a market cap of $162 million.</li>
<li>Planet 13 Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/PLNHF#OTC">PLNHF</a>): The price at market close was $0.96 with no significant change. Trading volume was 275,004.</li>
<li>Cresco Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>): The price at market close was $1.74 with a change of +$0.13 (+7.74%). Trading volume hit 438,517, with a market cap of $565 million.</li>
</ul>
<h3 class="wp-block-heading">Highs And Lows In 2024&nbsp;</h3>
The cannabis market has experienced several significant stock movements in recent months. On April 30, 2024, stocks soared after the DEA announced plans to reschedule cannabis to Schedule III, with Canopy Growth <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38536953/cannabis-stocks-react-to-dea-rescheduling-canopy-aurora-surge-tilray-wm-tech-hold-s">jumping</a> by 78.8% and Aurora Cannabis rising 46%. 
However, two weeks ago, following the DEA's decision to delay its final ruling, the sector saw a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/08/40580306/cannabis-stocks-plummet-by-up-to-16-on-dea-rescheduling-delay-could-this-be-the-buy">sharp decline</a>, with Curaleaf falling 15.68% and Green Thumb Industries dropping 10.15%. In contrast, Monday's gains following Trump's support for Amendment 3 were more modest, with a mean growth of 4.31%, suggesting a recovery but not on the same scale as the April surge.
Read Next: <a href="https://www.benzinga.com/markets/cannabis/24/09/40776937/trump-joins-millions-of-americans-who-support-rescheduling-cannabis-weed-industry-responds-to-fo">Trump &#8216;Joins Millions Of Americans&#8217; Who Support Rescheduling Cannabis: Weed Industry Responds To Former Pres&#8217; News</a>

Cannabis Stocks React To Trump's Marijuana Comments: See Which Ones Posted Solid Gains

The cannabis market is abuzz following former President Donald Trump&#8217;s recent comments supporting cannabis legalization in Florida.&nbsp;
During a podcast interview, Trump <a href="https://www.benzinga.com/markets/cannabis/24/09/40697992/trump-talks-legal-weed-on-lex-fridman-podcast-we-can-live-with-the-marijuana">backed the state&#8217;s recreational cannabis initiative </a>and emphasized the need for a lawful and regulated framework.&nbsp;
This comes as Florida prepares to vote on a ballot initiative in November, which could reshape the cannabis landscape.
Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter&nbsp;<a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.
<h3 class="wp-block-heading">Top Performers And Decliners After Trump&#8217;s Comments On Marijuana </h3>
Stocks in the cannabis sector showed varied reactions on Wednesday, after <a href="https://www.benzinga.com/markets/cannabis/24/09/40677600/harris-campaign-slams-donald-trump-over-cannabis-shift-calls-it-brazen-flip-flop">Trump&#8217;s comments</a>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YOLO#NYSE">YOLO</a>) AdvisorShares Pure Cannabis ETF led the gainers, climbing 3.48% to $3.27, reflecting investor optimism around potential federal changes.&nbsp;
(OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) Trees Corporation experienced a plunge, down 99.8%, closing at $0.0001. Among the notable losers, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) Canopy Growth dropped 3.37% to $4.87, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) Cronos Group slipped 1.79% to $2.20.
Other stocks remained relatively stable. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLRY#NASDAQ">TLRY</a>) Tilray Brands fell 1.19%, ending at $1.67, and (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) Aurora Cannabis dipped 1.37% to $5.76.&nbsp;
Meanwhile, (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) Sundial Growers climbed 2.53%, closing at $2.00, and (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) Trulieve Cannabis posted a 3.72% gain to $9.75, reflecting positive sentiment around these companies.
Read Also:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40712816/what-trump-learned-about-marijuana-that-desantis-did-not-and-why-the-gop-might-become-weed-frien">What Trump Learned About Marijuana That DeSantis Did Not And Why The GOP Might Become Weed-Friendly</a>
<h3 class="wp-block-heading">Stocks To Watch </h3>
<ul>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) AdvisorShares Pure US Cannabis ETF ended the day with a slight decline of 0.31%, closing at $6.48.</li>
<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IIPR#NYSE">IIPR</a>) Innovative Industrial Properties, a key player in cannabis real estate, dropped 0.82%, closing at $121.58, showing a more cautious response from investors.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) Green Thumb Industries posted a modest gain of 0.67%, closing at $9.83, indicating optimism.&nbsp;</li>
<li>(OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNA#OTC">MJNA</a>) Medical Marijuana Inc. surged 10%, finishing at $0.0011, reflecting renewed interest despite its low price point.</li>
</ul>
Read Next:&nbsp;<a href="https://www.benzinga.com/markets/cannabis/24/09/40713542/2024-election-cannabis-swing-state-voters-back-legalization-new-poll-reveals">2024 Election &amp; Cannabis: Swing State Voters Back Legalization, New Poll Reveals</a>

Trump's Marijuana Support Could Ignite Stock Surge – Are You Positioned To Benefit?

The U.S. Drug Enforcement Administration (DEA) <a href="https://www.benzinga.com/markets/cannabis/24/08/40567326/dea-delays-cannabis-rescheduling-decision-until-after-november-presidential-election">announced a delay on Monday</a> in its final ruling on cannabis rescheduling until after the <a href="https://www.benzinga.com/topic/2024-presidential-election">November presidential election</a>. The decision, which has created uncertainty in the market, pits Vice President Kamala Harris, a cannabis reform advocate, against former President Donald Trump, whose vice-presidential pick is opposed to legalization.
<h3 class="wp-block-heading">Market Responds With Sharp Declines</h3>
According to Benzinga Pro, the market's response was immediate and pronounced. The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSOS#NYSE">MSOS</a>) dropped over 10% in early trading, while individual cannabis stocks experienced significant declines.
Amid the market downturn some of the biggest losers included Curaleaf Holdings, Cresco Labs, and Cansortium.
<ul>
<li>Curaleaf Holdings (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CURLF#OTC">CURLF</a>) fell by 15.68% to $2.71, with 372,001 shares traded. </li>
<li>Trulieve Cannabis (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) saw a 10.36% decline, closing at $8.60 with a volume of 381,698 shares.&nbsp;</li>
<li>Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) dropped by 10.15%, ending the day at $9.56, with 274,985 shares changing hands.&nbsp;</li>
<li>Cresco Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CRLBF#OTC">CRLBF</a>) declined 13.89% to $1.55, on a volume of 435,673 shares. </li>
<li>Cansortium (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) experienced a significant loss, dropping 16.67% to $0.125 with 312,094 shares traded.</li>
<li>Conversely, Trees (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CANN#OTC">CANN</a>) demonstrated resilience gaining 9.01%.&nbsp;</li>
</ul>
Among these, Green Thumb Industries emerges as a compelling buy opportunity. Despite the significant drop, GTBIF&#8217;s larger market cap of $2.25 billion and its position as one of the industry leaders suggest strong recovery potential, making it a strategic buy for investors seeking long-term growth.
<ul>
<li>Get Benzinga&#8217;s exclusive analysis and the top news about the cannabis industry and markets daily in your inbox for free. Subscribe to our newsletter <a href="https://newsletteremail.benzinga.com/subscribe" target="_blank" rel="noreferrer noopener">here</a>. If you&#8217;re serious about the business, you can&#8217;t afford to miss out.</li>
</ul>
<h3 class="wp-block-heading">Analyst Perspective: Delay May Add Credibility</h3>
In his latest report, Pablo Zuanic, a senior analyst at Zuanic &amp; Associates, provided critical insights into the DEA's decision and its implications for the cannabis market. According to Zuanic, the announcement of an Administrative Law Judge (ALJ) hearing set to begin on December 2, 2024, was not entirely unexpected.
 "While the most bullish thesis had anticipated a Final Rule before the election, the scenario of hearings was always a possibility," Zuanic said. He highlighted that the MSOS ETF's pre-market drop to $6.19 was within the expected range, given the ongoing uncertainties.
Read Also: <a href="https://www.benzinga.com/markets/cannabis/24/08/40561136/trump-dislikes-having-people-in-jail-for-cannabis-will-he-legalize-if-elected-or-just-trying-to-">Trump Dislikes Having People In Jail For Cannabis: Will He Legalize If Elected Or Just Trying To Appeal To VP Harris&#8217; Voters?</a>
<h3 class="wp-block-heading">Potential Buying Opportunities Amid Volatility</h3>
Despite the downturn, Zuanic sees potential buying opportunities, particularly if stocks continue to be volatile. "We believe the likelihood of successful legal challenges is drastically reduced if all significant ‘affected or impacted parties' are heard during the ALJ hearing."
<h3 class="wp-block-heading">Political Uncertainty And Future Implications</h3>
However, Zuanic also warned of the political uncertainty that comes with the 2024 election. While a potential President Harris might complete the rescheduling process, the scenario under a Trump administration is less clear. "In the past, we would have said Trump might let the process die, but this is less obvious now," Zuanic said.
<h3 class="wp-block-heading">Risks And Rewards For Cannabis Investors</h3>
The report further emphasizes that investors should prepare for a possible downturn in cannabis stock prices, particularly if the MSOS ETF drops by 15-20% or falls below $5.&nbsp;
"If the MSOS ETF is down 15-20% in the next week, that would be ugly for investors. But, assuming Harris wins or Trump does not appoint a Sessions-type AG, we would use that as a buying opportunity," Zuanic said. 
As the market digests the implications of the DEA's decision, Zuanic's analysis provides a balanced perspective, highlighting both the risks and potential rewards for investors in the cannabis sector.
Read Next:<a href="https://www.benzinga.com/markets/cannabis/24/05/39011156/exclusive-we-analyzed-4-000-dea-marijuana-rescheduling-comments-heres-what-americans-really-thin"> EXCLUSIVE: We Analyzed 4,000+ DEA Marijuana Rescheduling Comments; Here&#8217;s What Americans Really Think</a>

The trading volume of a stock reflects the number of shares bought and sold within a given time. This is called liquidity. The term is used because it likens the ease of converting assets to cash to the fluidity of water. Why is this <a href="https://www.benzinga.com/cannabis">important for cannabis stocks</a>?
Liquidity determines how easily a stock can be bought or sold without significantly affecting its price. High liquidity is associated with lower transaction costs and greater flexibility, making it essential for both short-term traders and long-term investors.
<h2>High-Liquidity Cannabis Stocks</h2>
Several cannabis stocks are known for high trading volumes, indicating strong <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38206489/cannabis-markets-trading-volume-surges-up-292-viridian-capital-highlights-mixed-liq">liquidity</a>. Examples in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> include SNDL, Tilray Brands, Cronos Group and Aurora Cannabis.
<ul>
<li>SNDL: (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sndl#NASDAQ">SNDL</a>) Trading volume of 4,652,464, priced at $2.40 with a decline of 2.439%.</li>
<li>Tilray Brands (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tlry#NASDAQ">TLRY</a>): Trading volume of 26,783,844, priced at $1.95 with a decline of 2.0202%.</li>
<li>Cronos Group (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cron#NASDAQ">CRON</a>): Trading volume of 2,192,492, priced at $2.80 with a decline of 4.1379%.</li>
<li>Aurora Cannabis (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>): Trading volume of 2,178,950, priced at $7.40 with a gain of 0.542%.</li>
</ul>
<h3>Pros And Opportunities</h3>
<ul>
<li>Reduced Transaction Costs: High liquidity results in narrower bid-ask spreads, lowering the cost of buying and selling.&nbsp;The bid-ask spread is the difference between the highest price a buyer is willing to pay for a stock and the lowest price a seller is willing to accept.&nbsp;</li>
<li>Flexibility: Investors can easily adjust positions without significant price impacts.</li>
<li>Market Confidence: High <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38490666/how-big-caps-rewrite-valuation-rules-in-cannabis-cash-puzzle-for-companies-above-an">trading volumes</a> suggest strong market interest and confidence.</li>
</ul>
<h3>Cons And Risks&nbsp;</h3>
<ul>
<li>Volatility: High trading volumes can still be accompanied by price volatility, requiring careful timing for trades.</li>
</ul>
<h2>Low-Liquidity Cannabis Stocks</h2>
Some cannabis stocks have <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/04/38343689/whats-the-net-worth-of-these-420-underdogs-mid-tier-cannabis-retailers-cultivators-">lower trading volumes</a>, indicating less liquidity. Examples include Medical Marijuana (OTC: <a class="ticker" href="https://www.benzinga.com/stock/mjna#OTC">MJNA</a>), Trees (OTC: <a class="ticker" href="https://www.benzinga.com/stock/cann#OTC">CANN</a>),<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38828563/largest-cannabis-co-curaleafs-1-5b-projected-revenue-for-2025-analyst-raises-rating"> Curaleaf Holdings </a>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/curlf#OTC">CURLF</a>)&nbsp;and Green Thumb Industries (OTC: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTC">GTBIF</a>).
<ul>
<li>Medical Marijuana: Trading volume of 16,116,070, priced at $0.002 with a decline of 4.7619%.</li>
<li>Trees: Trading volume of 42,127, priced at $0.10 with a gain of 11.1111%.</li>
<li>Curaleaf Holdings: Trading volume of 616,467, priced at $5.33 with a decline of 5.9965%.</li>
<li>Green Thumb Industries: Trading volume of 466,633, priced at $12.35 with a decline of 5.8689%.</li>
</ul>
<h3>Pros And Opportunities</h3>
<ul>
<li>Potential High Returns: Lower liquidity stocks can offer high returns due to their smaller market caps and higher volatility.</li>
<li>Market Entry: Opportunity to invest early in potentially <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38772876/cannabis-reports-highlight-339m-and-297-6m-revenue-insights-in-curaleaf-and-truliev">high-growth companies</a>.</li>
</ul>
<h3>Cons And Risks:</h3>
<ul>
<li>Higher Transaction Costs: Wider bid-ask spreads can increase the cost of trading.</li>
<li>Price Impact: Significant trades can lead to large price swings, making it harder to execute orders at desired prices.</li>
<li>Market Confidence: Lower trading volumes may indicate less market interest and confidence.</li>
</ul>
High-liquidity stocks offer reduced transaction costs and flexibility but can still be volatile. Low-liquidity stocks may offer high returns but come with higher transaction costs and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38805354/analysts-may-need-to-revise-cannabis-stock-projections-for-2024-10-companies-surpas">potential price impacts</a>.
By understanding these factors, investors can make more informed decisions and optimize their strategies in the dynamic cannabis sector.
To learn more about the cannabis business and how to invest in the sector,&nbsp;don&#39;t miss the opportunity to join us at the&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/?UTM_source=article" target="_blank">19th Benzinga Cannabis Capital Conference</a>&nbsp;in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry&#39;s future. Secure your tickets now before prices increase by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank">this link</a>.
Photo: AI-Generated Image.

Mid Cap

Exclusives

Easy-To-Trade Cannabis Stocks: Insights Into How Trading Activity Affects These Investments

Four lesser-valued cannabis stocks showed&nbsp;positive performance on Monday, defying the broader sector&#39;s downtrend. These stocks&mdash;Medical Marijuana Inc., TILT Holdings, Trees Corp., and Village Farms International&nbsp;&mdash;present potential investment opportunities.
<h3>Positive Performers Among Smaller Cannabis Stocks</h3>
<ul>
<li>Medical Marijuana Inc. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/mjna#OTC">MJNA</a>), priced at $0.0021, has total assets of $72.775 million but faces financial challenges, including a net income loss of $280.475 million and an EBITDA of -$268.242 million. MJNA maintains a gross profit margin of 79.95%.</li>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/38741310/tilt-holdings-bold-financing-move-how-this-cannabis-companys-escalating-interest-rates-impact-it">TILT Holdings </a>(OTC: <a class="ticker" href="https://www.benzinga.com/stock/tlltf#OTC">TLLTF</a>), trading at $0.035, has total assets of $231.188 million and reported revenue of $165.956 million over the last twelve months. However, with a net income loss of $62.384 million and an EBITDA of -$22.018 million, TILT&#39;s profitability is under pressure. Its gross profit margin stands at 9.54%.</li>
<li>Trees Corp. (OTC: <a class="ticker" href="https://www.benzinga.com/stock/cann#OTC">CANN</a>), at $0.1 per share, lists total assets of $23.247 million. Despite a negative tangible book value per share and a net income loss of $7.082 million, Trees Corp. maintains a gross profit margin of 25.76%. Trees recently reported its Q1 2024 results, revealing total revenue of $3.686 million and an operating loss of $477,348​.</li>
<li><a href="https://www.benzinga.com/markets/cannabis/24/05/38701259/village-farms-reports-record-q1-canadian-cannabis-sales-following-49-yoy-increase-continues-to-s">Village Farms International</a> (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>), priced at $1.278, holds total assets of $458.439 million with a current ratio of 2.076. With revenue of $299.024 million, VFF shows resilience despite a net income loss of $28.014 million. Their gross profit margin of 19.87% and a market cap of $138.914 million indicate a potential for recovery.</li>
</ul>
<h3>Operational Efficiency</h3>
Medical Marijuana Inc. demonstrates <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38805354/analysts-may-need-to-revise-cannabis-stock-projections-for-2024-10-companies-surpas">operational efficiency </a>with a gross profit margin of 79.95%, indicating strong control over production costs despite its financial challenges. This margin suggests that MJNA could be managing effectively its cost of goods sold relative to its revenue.
On the other hand, Trees Corp. maintains a gross profit margin of 25.76%, reflecting its ability to generate revenue from its operations. Despite reporting a net income loss of $7.082 million and an operating loss in its recent Q1 2024 results, both companies&#39; operational metrics highlight their potential to sustain business activities and improve financial performance.
To learn more about the cannabis business and how to invest in the sector,&nbsp;don&#39;t miss the opportunity to join us at the&nbsp;<a href="https://www.benzinga.com/events/cannabis-conference/?UTM_source=article" target="_blank">19th Benzinga Cannabis Capital Conference</a>&nbsp;in Chicago this October 8-9. Engage with top executives, investors, policymakers, and advocates to explore the industry&#39;s future. Secure your tickets now before prices increase by following&nbsp;<a href="https://www.eventbrite.com/e/benzinga-capital-conference-cannabis-fall-2024-tickets-858948065787?aff=oddtdtcreator" target="_blank">this link</a>.
<h3>Comparison To Larger Cannabis Companies</h3>
When compared to larger <a href="https://www.benzinga.com/markets/cannabis/24/05/38922599/69-of-voters-including-majority-of-republicans-support-marijuana-legalization-did-you-catch-that">cannabis</a> companies, the valuation difference is significant. <a href="https://www.benzinga.com/markets/cannabis/24/05/38748891/curaleaf-reports-q1-2024-revenue-of-339m-48-gross-margin-amid-strategic-global-expansion">Curaleaf Holdings</a> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/curlf#OTC">CURLF</a>) is priced at $5.18, down 8.64%, and AdvisorShares Pure US Cannabis ETF (ARCA: MSOS) is at $9.08, down 5.47%. Canopy Growth (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cgc#NASDAQ">CGC</a>) is at $10.48, down 3.46%, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38772876/cannabis-reports-highlight-339m-and-297-6m-revenue-insights-in-curaleaf-and-truliev">Trulieve Cannabis</a> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/tcnnf#OTC">TCNNF</a>) at $11.73, down 6.01%, and <a href="https://www.benzinga.com/markets/cannabis/24/05/38716589/green-thumb-industries-revenue-increases-11-in-q1-2024-were-off-to-a-great-start-says-pres">Green Thumb Industries</a> (OTC: <a class="ticker" href="https://www.benzinga.com/stock/gtbif#OTC">GTBIF</a>) at $12.59, down 4.08%. Only Aurora Cannabis (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/acb#NASDAQ">ACB</a>) is up, priced at $7.51, up 1.76%.
In contrast to these larger names, the smaller stocks in green today have shown modest gains: MJNA at 4.7619%, TLLTF at 1.4493%, CANN at 11.1111%, and VFF at 1.4286%.
Investors may consider these lesser-valued stocks for their potential to navigate a volatile market. Each company&#39;s financial metrics and <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/05/38803783/will-pharma-and-healthcare-have-competitive-edge-in-cannabis-post-rescheduling-data">operational efficiencies</a> could offer entry points for those looking to diversify within the <a href="https://www.benzinga.com/markets/cannabis/24/05/38881456/bidens-greenlight-what-to-know-about-fed-regulated-marijuana-markets-legal-circuits-and-complian">cannabis sector</a>.
Photo: AI-Generated Image.&nbsp;

Penny Stocks

TLLTF

Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?

Heritage Cannabis Holdings Corp. (CSE:<a class="ticker" href="https://www.benzinga.com/stock/CANN#CSE">CANN</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/HERTF#OTCQX">HERTF</a>) announced on Tuesday that alongside its subsidiaries it sought and obtained an order for creditor protection from the Ontario Superior Court of Justice under the Companies Creditors Arrangement Act.
"The difficult but necessary decision to commence CCAA proceedings was made after careful consideration of the Company's financial position while evaluating all available alternatives and engaging in significant consultation with legal and financial advisors," the company said in a press release.
The Toronto-based cannabis producer also said that BJK Holdings Ltd., its senior secured lender, made a demand to the company for payment in full of certain indebtedness owing by the Heritage Group to the lender totaling $8,421,088.87.
Heritage has entered into binding agreements to sell its real estate properties in Ontario and British Columbia to BJK Developments Ltd. for a net purchase price of $9,714,475 and lease the Ontario and BC <a href="https://www.benzinga.com/markets/cannabis/23/10/35512613/multi-million-dollar-real-estate-deal-slashes-debt-for-toronto-cannabis-maker">Property back from the purchaser in October.</a>
<figure class="wp-block-image aligncenter size-full"><a href="https://www.benzinga.com/events/cannabis-conference/"><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/04/03121548/2231044_CCCFloridaGIF_V2_031124-1-7.gif" alt="" class="wp-image-276062" /></a></figure>
The company said at the time the purchase would be used to set off the amount owing by the company to its lender, BJK Holdings Ltd., a related entity of the purchaser, reducing the company's remaining term debt by roughly 64% to $5,256,379. The remaining term financing, as amended within a third amending agreement, has been extended through to Jan. 31, 2025. Additionally, the company said it retains its revolving line of credit of up to $5 million with BJK, which has also been extended until the same date.
According to a Wednesday update, the company's initial order includes:
<ul>
<li>A stay of proceedings in favor of the company and its Canadian subsidiaries; and</li>
<li>The appointment of KPMG Inc. as monitor of the company.</li>
</ul>
Heritage said its board of directors will remain in place and management will remain responsible for the day-to-day operations, under the supervision of the monitor.
The company plans to seek approval of a sale and investment solicitation process. If approved, the move would allow interested parties to participate in the process by the SISP procedures.
Canadian Securities Exchange is expected to place the company under delisting review.
Heritage recently reported a slight year-over-year decrease in fourth-quarter revenue to CA$7.98 million ($5.9 million), from <a href="https://www.benzinga.com/markets/cannabis/24/02/37341729/heritage-cannabis-co-boosts-gross-margin-over-50-in-2023-thanks-to-this-smart-move">CA$8.03 million in the prior year&#8217;s period.</a>
It also reported an increase in gross margin of more than 50% for 2023 and 628% for the fourth quarter compared to last year.
In 2023 it reported a comprehensive loss of CA$19.9 million, down from CA$23.9 million in the same period of 2022.
<h3 class="wp-block-heading">HERTF Price Action</h3>
Heritage Cannabis' shares traded 76.67% lower at $0.0028 per share at the time of writing on Wednesday morning.
The <a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Benzinga Cannabis Capital Conference</a> is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at <a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">The Diplomat Beach Resort</a> will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
<a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener">Get your tickets now on </a><a href="http://bzcannabis.com" target="_blank" rel="noreferrer noopener">bzcannabis.com</a><a href="https://www.benzinga.com/events/cannabis-conference/" target="_blank" rel="noreferrer noopener"> – Prices will increase very soon!</a>

Comments

Trees

Trees (CANN) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga